BioCrude Technologies USA, Inc. Quarterly Revenues in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
BioCrude Technologies USA, Inc. quarterly Revenues history and growth rate from Q2 2019 to Q3 2024.
  • BioCrude Technologies USA, Inc. Revenues for the quarter ending September 30, 2024 was $0.000.
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-10
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.